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According to the EWG report, the TRI
data reveal a "shocking practice by
American fertilizer companies. They rou-
tinely 'recycle' toxic factory waste of all
kinds into fertilizers.... The stuffis laden
with lead, cadmium, arsenic, dioxin, and
other high risktoxics that end up in fertiliz-
ers widely used by farmers in the United
States." The group charged that state rules
on the practice amount to a "loophole-rid-
dled regulatory 'safety net."' Although the
EWG report does not say that actual harm
from the practice has been demonstrated,
Todd Hattenbach, an EWG researcher,
says, "It's a dangerous practice because
nobody is looking dosely [at it]. The EPA
is doing risk assessments, but they don't
know what's going into the waste streams
right now." The EWG contention is that,
rather than having to demonstrate injury,
companies should be required to demon-
strate the safety of the practice before it is
allowed.
John Mortvedt, a retired soil scientist
who studied fertilizer contamination for 20
years at the National Fertilizer and
Environmental Research Center in Muscle
Shoals, Alabama, says the Seattle Times
report was more sensational than it needed
to be. But he agrees that the story exposed
the RCRA loophole, the so-called "K061"
provision, which allows the unregulated
transfer ofdust-a waste product from the
electric arc furnaces used in steel mills-to
fertilizer companies. The dust contains
zinc, an essential plant micronutrient, as
well as lead, arsenic, cadmium, and nickel.
According to the EWG report, nearly 30%
ofthe industrial waste that became fertilizer
originated at steel mills.
Due to the reporting system used in the
TRI, the 271 million pounds ofwaste that
became fertilizer between 1990 and 1995
mayactually make up onlypart ofthe total
transfers. Nevertheless, say critics of the
EWG report, the total amount of waste
recycled into fertilizer is probably a tiny
fraction ofoverall fertilizer use (estimated at
54 million tons in 1995 alone).
Furthermore, once the material is spread on
farmland, it is diluted byincorporation into
the soil. When contaminants present in a
parts-per-million or parts-per-billion
amount are spread on soil, Mortvedt notes,
"They become inconsequential at some
level." Natural soils, he adds, generally con-
tain someheavymetals anyway.
Waste material can be safely recycled in
some cases. In 1996, for example,
Consolidated Papers recycled 161,000 tons
ofpaper mill sludge on farms near its mill
in Wisconsin Rapids, Wisconsin. Nitrogen
in the sludge replaced conventional fertiliz-
er, and the organic material helped the
sandy soil hold water. The sludge was ana-
lyzed before disposal for 125 pollutants,
induding dioxins, heavymetals, and organ-
ic pollutants. Similar testing is also required
forsewage sludge, which is commonly recy-
dedon farmland underEPAregulation [see
EHP105(1):32-36 (1997)].
The fertilizer industry says there is no
cause for alarm. "Based on all the evidence
to date, industry has concluded that there's
no problem," saysJennifer Lombardi, com-
munications director for the California
Fertilizer Association. "But if conclusions
based on science say there is a problem,
industry would be supportive ofa way to
address that."
However, the issue of heavy metals in
fertilizer is getting attention. Washington
State has enacted regulations requiring
contamination tests for fertilizers, but the
tests look just for heavy metals. Texas has
adopted rules thatwill allow the same con-
centrations of contaminants in fertilizer
that are currently allowed for biosolids.
California, which the EWG reported had
received the greatest amount of industrial
waste-derived fertilizer (37.6 million
pounds), is completing a facilitative rule-
making process on heavy metals in fertiliz-
er. By 1 March 1999, a state panel is sup-
posed to suggest whether the California
Department of Food and Agriculture
should issue further regulations.
Meanwhile, the American Association of
Plant Food Control Officials, a group of
fertilizer regulators, is developing a uni-
form standard on heavy metal content that
will be presented to all U.S. states, Puerto
Rico, and Canada for adoption.
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Spraying sludge. The practice of recycling industrial wastes into fertilizer has come under fire from
opponents who are concerned thattoxic contaminants inthe sludge mayreach food and other crops.
The EPA has started a risk assessment
of heavy metals in fertilizer. According to
one EPA offilcial involved in the discus-
sions, the agency reviewed available data
on fertilizer composition and found that
"some fertilizer may have arsenic, lead, and
cadmium-the three primary culprits-at
levels they maybe should not have, but it's
not an emergency out there." However,
the EWG maintains that the EPA is not
able to calculate the risks because it lacks
enough dataonwhat components are actu-
ally contained in fertilizer. An upcoming
revision of RCRA's provisions, scheduled
for publication in early 2000, may close
the K061 loophole, but with state regula-
tion in the offlng, the EPA is unlikely to
write comprehensive fertilizer regulations.
The EWG's vice president for research,
Richard Wiles, advocates halting the use of
industrial waste as fertilizer, saying, "We
need a moratorium until we have a reason-
able program of testing waste before it's
manufactured into fertilizer."
Herbal Medicine is Potent
Estrogen
When a patient complained to oncologist
Robert DiPaola ofthe Cancer Institute of
New Jersey of breast tenderness, muscle
pain, and loss of libido-all classic side
effects ofestrogen therapy-the doctor was
perplexed. His patient had rejected hor-
mone treatment,for prostate cancer because
of its abI4orrent side effects and limited
potential foracure.
The patient also showed signs ofestro-
gen's good effects. His level of prostate-
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specific antigen (PSA), an indicator of
prostate cancer, had plummeted. The
patient admitted he was taking PC-SPES,
an herbal remedy derived from nine sepa-
rate herbs and mushrooms that is sold
over the Internet. DiPaola soon began to
notice similar effects in other patients tak-
ing PC-SPES. He presented the case to
Michael Gallo, the institute's associate
director for basic science, who recalls: "I
said, 'We've got an estrogen here. Let's
take a look at these herbs."'
DiPaola and Gallo turned their atten-
tion toward the men, conducting a clinical
trial involving eight cancer patients taking
the herbal remedy. They found that PC-
SPES causes a decrease in testosterone and
PSA, along with other symptoms of estro-
gen use. The researchers then enlisted
George Lambert, a clinical pharmacologist
at the NIEHS Environmental and
Occupational Health Sciences Institute in
Piscataway, New Jersey, to examine PC-
SPES for estrogenic activity.
A yeast-based assay used by Lambert
confirmed Gallo and DiPaola's suspicions
that PC-SPES acts as an estrogen. "This is
as potent as a drug," says DiPaolo. Says
Gallo, "It was the collaboration of the
expertise of these two centers that allowed
us to make this discovery. This is the type
of bioassay that should be done on herbal
products." The three researchers and nine
other colleagues reported their findings in
the 17 September 1998 issue of the New
EnglandJournalofMedicine (NEJM).
Journal editors Marcia Angell and
Jerome Kassirer used the report as a spring-
board for their editorial calling on the
Food and Drug Administration (FDA) to
require the same rigorous testing of alter-
native medicines that it requires ofconven-
tional drugs. PC-SPES, like other plant-
derived substances, vitamins, minerals, and
amino acids, is considered a dietary supple-
ment. The FDA regulates supplement
labeling but requires no testing.
The NEJM report hit a nerve among
those who view herbal remedies as distinct-
ly different-and safer-than their syn-
thetic cousins. "I believed there was a pos-
sibility of a potential cure with this," says
Mario Menelly, a PC-SPES user and sub-
ject in DiPaola's clinical trial. "It's nothing
but herbs. It shouldn't hurt me." The arti-
cle prompted a spate ofletters to the editor
from both sides of the issue, scheduled to
be published in a future issue ofNEJM.
In the long run, PC-SPES may be no
more harmful than conventional treat-
ment, but nobody knows for sure. Even
proponents ofherbal remedies recommend
more clinical trials. "We need large-scale
studies," says Sophie Chen, a professor of
medicine at New York Medical College in
Valhalla, who developed PC-SPES five
years ago. "I would like to see it become a
prescription medicine."
The yeast assay used to screen PC-
SPES is among several developed in recent
years that can measure estrogenic activity
quickly and inexpensively. For a half-cen-
tury, the only assay for estrogen required
mice. Scientists fed mice the substance
under study for several days, then sacrificed
them and weighed their uteruses.
Estrogenic substances cause the uterus to
enlarge.
Mice assays are still considered the gold
standard-DiPaolo and Gallo followed the
yeast screening with a mouse assay-but
may soon be replaced with yeast and other
cellular assays. "It's less expensive," explains
Elizabeth Jeffery, an associate professor of
nutritional toxicology at the University of
Illinois at Urbana-Champaign. "It's less
labor-intensive. It's much more rapid." The
yeast assay initially was used to screen PC-
SPES for estrogen that binds to alpha
receptors, which are found primarily in
reproductive tissue. A few years ago,
researchers discovered a second receptor,
beta, that binds to estrogen in the brain,
bone, kidneys, and other organs. Lambert's
group is now developing a greater array of
hormone receptor assays to screen the
herbal remedy with beta receptors.
The yeast assay was constructed to sim-
ulate response of the human estrogen
receptor system when exposed to an estro-
genic mixture. When an estrogenic sub-
stance is added to the medium, the yeast
proliferate. If the substance is not estro-
genic, the yeast die. Like other screening
assays, the yeast assay has limitations. It will
not indicate activity in compounds that
become estrogenic only after they're oxi-
dized in the body, such as the pesticide
methoxychlor. Differences in the perme-
ability ofyeast and human cell membranes
also could confound results. "Something
may not be able to get through the cell wall
ofyeast even though it gets through the cell
membrane ofhumans," Lambert says.
To some cancer patients, like Mario
Menelly, yeast assays and clinical trials
don't mean a thing. Menelly is sticking
with an unregulated mixture ofherbs, even
if it causes the same side effects as conven-
tional, hormonal drugs. "It's only herbs,"
he says. "It comes from the earth."
His attitude is common. More than
halfofU.S. adults use dietary supplements,
according to the FDA. Estimates of alter-
native-therapy usage among cancer
patients range from 5% to 60%. "This
isn't just a fad that'll go away in two
months," says John Cardellina, director of
botanical science for the Council for
Responsible Nutrition, a trade organiza-
tion representing manufacturers of dietary
supplements. Cardellina laments the lack
of information about dietary supplements
for both consumers and physicians.
"Doctors do not know enough about
botanical products," he says. "They don't
know what to expect in terms of efficacy
and side effects. This [NEJM report] may
get oncologists to look at PC-SPES and
what it can do."
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